Parkway Shenton partners Neurowyzr for digital brain health screening

HEALTHTECH startup, Neurowyzr has partnered medical group, Parkway Shenton in launching its digital brain health screening for their patients.

The Digital Brain Function Scan is registered with the Singapore Health Sciences Authority, and allows patients to use any connected digital device such as a mobile phone, tablet, laptop or PC to complete a browser-based assessment. Upon completion, patients will receive a report that the prescribing physician will discuss with them in-depth.

This test will save time and costs of administering traditional cognitive tests that are done in-person with pen and paper that takes up hours of patient and physician time, and costs a few thousand dollars according to Neurowyzr.

“This partnership with Neurowyzr gives Parkway Shenton the unique capability to promote brain health and help our patients play an active role in identifying and preventing problems with cognition,” said Dr Edwin Chng, medical director, Parkway Shenton.

This test allows for early detection of brain health problems, preventing or reducing problems associated with cognitive decline, stroke, long Covid brain damage, Parkinson’s disease and dementia. Neurowyzr’s tests have about the same accuracy at the current pen and paper tests between 91 per cent and 93 per cent.

With studies showing from the age of 30, about 10 per cent of people begin to experience mild cognitive impairment, the number increases to 25 per cent among people aged 50 and 40 per cent at 60 years old. This condition could be stemming from other underlying conditions such as hypertension, diabetes, obesity among others. The condition also may stem from early liver, kidney, lung and heart failure or dysfunction, making early detection crucial.

SEE ALSO

Shaping the future of healthcare with digitalisation and innovation

DECODING ASIA

Navigate Asia in
a new global order

Get the insights delivered to your inbox.

Neurowyzr is looking to bring these tests to other parts of South-east Asia, India and Australia.

“The sooner healthcare providers can intervene when cognitive issues arise, the better the outcomes are for the population. With the increasing medical, social and economic burden of chronic non-communicable diseases, governments and organisations should be paying closer attention to the brain health of citizens and employees. We are excited to work with a new partner who recognises this, and look forward to signing with other like-minded organisations in the months ahead,” said Pang Sze Yunn, chief executive, Neurowyzr.